Real-world evidence in gynecologic cancers presented at key oncology conferences in the United States: Distribution and factors related to high-tier acceptance
RWE abstracts were accepted for presentation more frequently at SGO versus ASCO, and majority of them were presented as posters. While RWE abstracts are prevalent and provide valuable data for healthcare decision-making, they do not always achieve the visibility of CTs.
Authors
- Matthew Monberg (ORCID: https://orcid.org/0009-0006-7462-4782)
- Ramu Periyasamy
- Elizabeth A. Szamreta (ORCID: https://orcid.org/0000-0001-7723-3388)
- Bhavani Yamsani
- Pattabhi Machiraju
- Mansi Modi
- Neetu Menghani
Institutions
- Rutgers, The State University of New Jersey (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Environmental and Occupational Health Sciences Institute (US)
- Bangalore Medical Center (IN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-04-22
- DOI
- https://doi.org/10.1371/journal.pone.0321654
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00